In the BioHarmony Drug Report Database

"Preview" Icon

Halofantrine

Halfan (halofantrine) is a small molecule pharmaceutical. Halofantrine was first approved as Halfan on 1992-07-24. It is used to treat falciparum malaria, malaria, and vivax malaria in the USA. It is known to target potassium voltage-gated channel subfamily H member 2.

 

Trade Name

 

Halfan
 

Common Name

 

halofantrine
 

ChEMBL ID

 

CHEMBL1107
 

Indication

 

falciparum malaria, malaria, vivax malaria
 

Drug Class

 

Image (chem structure or protein)

Halofantrine structure rendering